Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice

Generated: June 25, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,167,242

« Back to Dashboard

Summary for Patent: 5,167,242

Title: Nicotine-impermeable container and method of fabricating the same
Abstract:The present invention relates to a nicotine-impermeable container and a method for fabricating same. Additionally, the invention relates to a nicotine inhaling device which allows a user to ingest nicotine vapors orally. The nicotine inhaling device of the present invention is primarily directed to a device which can be used as a smoking cessation aid.
Inventor(s): Turner; James E. (Atascosa, TX), Ellis; Michael P. (San Antonio, TX), Oldham; Ronald G. (San Antonio, TX), Hill; Ira (Locust, NJ), Malmborg; Bengt E. (Helsingborg, SE), Andersson; Sven-Borje (Od.ang.kra, SE)
Assignee: Kabi Pharmacia Aktiebolaq (SE)
Application Number:07/535,967
Patent Claim Types:
see list of patent claims
Delivery; Composition;

No matches for this query

International Patent Family for Patent: 5,167,242

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria174805► Subscribe
Australia642506► Subscribe
Australia8002791► Subscribe
Brazil9106537► Subscribe
Canada2084771► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Chinese Patent Office
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus